In recent job cuts at the FDA, experts are worried about potential widespread effects. They fear that reducing staff could slow down the approval process for new medications, affecting the availability of important drugs like Advil or Lipitor.
The Trump administration’s decision to cut the FDA’s staff might jeopardize crucial work related to medical devices and food safety. It could also hinder the agency’s ability to gain knowledge in new areas. This might affect the FDA’s work on medications like Advil and Tylenol.